Description
Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities. This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region.
Combined, these countries represent a population of 636 million—a large potential IVD market audience. Brazil and Mexico represent the two largest countries in terms of population, accounting for more than half of LATAM total population. For this reason, these two countries have been the focus for many IVD suppliers in recent years. However, as economic conditions strengthen in other countries and demand increases for quality health services, there are additional opportunities in countries such as Chile, Colombia and Peru.
The estimated GDP for the countries studied in this research is an average of 1.4% annual decline for the year 2019 but consists of a significant declining GDP for Venezuela. Excluding Venezuela, the region records 1.2%. GDP growth. The per capita GDP is reported at $15,985 on average for the region.
Segments Analyzed
The segments under analysis include reagents, consumables, calibrators and controls of the following sub-segments:
- Clinical Chemistry: substrates, enzymes, homogeneous immunoassays, proteins, ISE (non POC), HBA1c (non POC).
- Critical Care: blood gas and electrolytes, including rapid tests.
- Urinalysis: manual, semi-automated and automated. Include urine strips, urine sediment reagents and disposables in automated systems.
- Microbiology Immunoassays: HIV, Hepatitis, ToRCH, Influenza, Syphilis, and other infectious diseases agents. Excludes tests processed in blood banks.
- Immunoassay (non-microbiology): hormones, tumor markers, bone markers, oncology markers, autoimmunity, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT. Also includes non-POC drugs of abuse testing and therapeutic drug monitoring.
- Cardiac Markers: non POC cardiac markers (Troponine, BNP, CK-MB, Homocystein, Myoglobin).
- Blood Banking: immunotyping and infectious diseases screening.
- Microbiology: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma.
- Molecular Microbiology: HIV, Hepatitis, STDs (CT, NG, HPV), MRSA, MTB, Sepsis, EBV, CMV, Respiratory Panel, and other infectious diseases agents. Also includes multiplex NAT.
- POC: all POC tests for cardiology, toxicology, coagulation, infectious diseases. Excludes POC glucose testing.
- Glucose Testing: diabetes glucose monitoring strips.
- Primary Staining Histology: PAP, HE and other primary stains.
- Advanced Staining Histology: IHC, ISH, FISH, primary and secondary antibodies.
- Hematology: manual, semi-automated and automated (CBC and 5 Diff).
- Coagulation: PT, APTT, coagulation factors, Fibrinogen, FDP, Lupus Anticoagulant and other analytes from the thrombosis and hemostasis pathway.
- Flow Cytometry: manual, semi-automated and automated flow cytometry for CD4/CD8 (AIDS), leukemia, lymphoma.
- Other Molecular: oncology, hemato-oncology, hereditary diseases, hemostasis and hematology diseases.
Research Methodology
Interviews with IVD market participants, public and private laboratory operations managers, government representatives and health professionals were the primary source of information. Primary research focused on the seven countries highlighted in this report: Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela. Other LATAM countries’ markets were estimated using mostly secondary research – which consisted of medical journals, healthcare data from government agencies, import/export databases (specifically focusing on HS Codes 90 and 98), registered business databases (specifically focusing on NAICS code 325413) and other information. In all cases, information was compared to the previous IVD Latin America edition, which includes VA Consultora y Asociados data as well as to secondary information from other sources. As secondary source of information statistics from public tenders, as well as output data provided by the main funding entities and reagents, inputs and instrument imports made by labs were used.
Depending on the source, there are differences in the information about the countries of the region. Quality data reporting varies by country and is a primary weakness in the region. Some countries report quality data while others have low quality, incomplete information or the information is manipulated in some way. Kalorama Information has reviewed data from multiple sources, both country-reported and global databases, to generate the most reliable and complete information available.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
- OVERVIEW
- Table 1-1 Population and GDP in Seven Leading IVD Latin American Countries
- SIZE OF THE MARKET AND GROWTH
- Figure 1-1: IVD Market in Latin America, 2020-2025
- LATIN AMERICAN IVD MARKET BY COUNTRY
- Figure 1-2: Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), % 2020
- GROWTH OF IVD MARKET IN LATIN AMERICA BY COUNTRY, CAGR 2020 TO 2025
- Figure 1-3: Average Growth of Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), CAGR 2020 to 2025
- IVD COMPANY MARKET SHARE IN LATIN AMERICA
- Figure 1-4: IVD Market Share in Latin America, by Company, 2020
- SEGMENTS DEFINITION
- MARKET LEADERSHIP IN IVD SEGMENTS
- Table 1-2: Latin American Market Leaders in Selected Segments (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Microbiology, Molecular Microbiology, Histology, Hematology, Coagulation, Flow Cytometry)
- RESEARCH METHODOLOGY
CHAPTER 2: ARGENTINA
- OVERVIEW AND DEMOGRAPHICS
- Table 2-1: Key Facts, Argentina (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Argentina
- Table 2-1: Health System and Indicators, Argentina (Physician Density, Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 2-2: Economic Profile, Argentina (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Argentina
- IVD MARKET ANALYSIS – ARGENTINA
- Total Market Size
- Table 2-3: Argentinian IVD Market by Sector, 2020-2025 (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) in $US thousands
- IVD Market in Argentina by Segment
- Figure 2-1: Argentinian IVD Market Distribution by Sector (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 2-2: Average Growth of IVD Markets in Argentina (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Argentina
- Figure 2-3: Clinical Chemistry Market in Argentina by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-4: Clinical Chemistry Market in Argentina, Market Participant Share (%), 2020
- General Chemistry Market in Argentina
- Critical Care Market in Argentina
- Urinalysis Market in Argentina
- Immunoassay Market in Argentina
- Figure 2-5: Immunoassay Market in Argentina by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-6: Immunoassay Market in Argentina, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Argentina
- Cardiac Markers (non-POC) Market in Argentina
- Non-Microbiology Immunoassay Market in Argentina
- Blood Banking Market in Argentina
- Microbiology Market in Argentina
- Figure 2-7: Microbiology Market in Argentina by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-8: Microbiology Market in Argentina, Market Participant Share (%), 2020
- ID/AST Market in Argentina
- Molecular Microbiology and Nucleic Acid Test Market in Argentina
- POC Market in Argentina
- Figure 2-8: POC Market in Argentina by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 2-9: POC Market in Argentina, Market Participant Share (%), 2020
- POC Glucose Testing Market in Argentina
- Histology Market in Argentina
- Figure 2-10: Histology Market in Argentina, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Argentina
- Coagulation Market in Argentina
- Flow Cytometry Market in Argentina
- Non-infectious Disease Molecular Market in Argentina
- Market Participants
- Becton Dickinson Argentina
- Bio-Rad Laboratories, Inc.
- Rochem Biocare Argentina S.A.
- Siemens Healthcare S.A. Argentina
- Market Share
- Table 2-4: IVD Market Share by Company, Argentina (%), 2020
- Figure 2-11: IVD Market Argentina, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 3: BRAZIL
- OVERVIEW AND DEMOGRAPHICS
- Table 3-1: Key Facts, Brazil (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Brazil
- Table 3-2: Health System and Indicators, Brazil (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 3-3: Economic Profile, Brazil (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Brazil
- IVD MARKET ANALYSIS – BRAZIL
- Total Market Size
- Table 3-4: Brazil IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Brazil by Segment
- Figure 3-1: Brazil IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 3-2: Average Growth of IVD Markets in Brazil (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Brazil
- Figure 3-3: Clinical Chemistry Market in Brazil by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-4: Clinical Chemistry Market in Brazil, Market Participant Share (%), 2020
- General Chemistry Market in Brazil
- Critical Care Market in Brazil
- Urinalysis Market in Brazil
- Immunoassay Market in Brazil
- Figure 3-5: Immunoassay Market in Brazil by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-6: Immunoassay Market in Brazil, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Brazil
- Immunoassay (non-Microbiology) Market in Brazil
- Cardiac Marker (non-POC) Market in Brazil
- Blood Banking Market in Brazil
- Microbiology Market in Brazil
- Figure 3-7: Microbiology Market in Brazil by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-8: Microbiology Market in Brazil, Market Participant Share (%), 2020
- Molecular Microbiology Market in Brazil
- POC Market in Brazil
- Figure 3-9: POC Market in Brazil by Segment (glucose and other), Estimate and Forecast, 2020-2025 $US thousands
- Figure 3-10: POC Market in Brazil, Market Participant Share (%), 2020
- Histology Market in Brazil
- Figure 3-11: Histology Market in Brazil, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 $US thousands
- Hematology Market in Brazil
- Coagulation Market in Brazil
- Flow Cytometry Market in Brazil
- Non-infectious Disease Molecular Market in Brazil
- Market Participants
- Abbott Laboratorios do Brazil Ltda.
- Bio-Rad Laboratorios Brasil Ltda
- Danaher – Beckman Coulter
- Ortho-Clinical Diagnostics
- Siemens Healthcare Diagnostics SA
- Sysmex do Brasil Industria e Comercio Ltda.
- Wiener Laboratories SAIC/Labinbraz
- Market Share
- Table 3-5: IVD Market Share by Company, Brazil, 2020
- Figure 3-12: IVD Market Brazil, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 4: CHILE
- OVERVIEW AND DEMOGRAPHICS
- Table 4-1: Key Facts, Chile (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Chile
- Table 4-2: Health System and Indicators, Chile (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 4-3: Economic Profile, Chile (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Chile
- IVD MARKET ANALYSIS – CHILE
- Total Market Size
- Table 4-4: Chile IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 in $US thousands
- Figure 4-1: Chile IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 4-2: Average Growth of IVD Markets in Chile (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Chile
- Figure 4-3: Clinical Chemistry Market in Chile by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 4-4: Clinical Chemistry Market in Chile, Market Participant Share (%), 2020
- Urinalysis Market in Chile
- Immunoassay Market in Chile
- Figure 4-5: Immunoassay Market in Chile by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 4-6: Immunoassay Market in Chile, Market Participant Share (%), 2020
- Microbiology Immunoassay Market in Chile
- Immunoassay (non-Microbiology) Market in Chile
- Cardiac Marker (non-POC) Market in Chile
- Blood Banking Market in Chile
- Microbiology Market in Chile
- Molecular Microbiology and NAT Market in Chile
- POC Market in Chile
- Figure 4-7: POC Market in Chile by Segment (glucose, other), Estimate and Forecast, 2020-2025 $US thousands
- Glucose Testing Market in Chile
- Histology Market in Chile
- Figure 4-8: Histology Market in Chile, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 $US thousands
- Hematology Market in Chile
- Coagulation Market in Chile
- Flow Cytometry Market in Chile
- Non-infectious Disease Molecular Market in Chile
- Market Participants
- Siemens Healthcare Medical Equipment SPA
- Market Share
- Table 4-5: IVD Market Share by Company, Chile, 2020
- Figure 4-9: IVD Market Chile, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 5: COLOMBIA
- OVERVIEW AND DEMOGRAPHICS
- Table 5-1: Key Facts, Colombia (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Colombia
- Table 5-2: Health System and Indicators, Colombia (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 5-3: Economic Profile, Colombia (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Colombia
- IVD MARKET ANALYSIS – COLOMBIA
- Total Market Size
- Table 5-4: Colombia IVD Market by Sector, (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Colombia by Segment
- Figure 5-1: Colombia IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 5-2: Average Growth of IVD Markets in Colombia (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Colombia
- Figure 5-3: Clinical Chemistry Market in Colombia by Segment (general chemistries, urinalysis), Estimate and Forecast, 2020-2025 $US thousands
- Figure 5-4: Clinical Chemistry Market in Colombia, Market Participant Share (%), 2020
- Immunoassay Market in Colombia
- Figure 5-5: Immunoassay Market in Colombia by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 5-6: Immunoassay Market in Colombia, Market Participant Share (%), 2020
- Microbiology Market in Colombia
- Figure 5-7: Microbiology Market in Colombia by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 5-8: Microbiology Market in Colombia, Market Participant Share (%), 2020
- Molecular Microbiology and NAT Market in Colombia
- POC Market in Colombia
- Figure 5-9: POC Market in Colombia by Segment (glucose, other), Estimate and Forecast, 2020-2025 $US thousands
- Histology Market in Colombia
- Figure 5-10: Histology Market in Colombia, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Colombia
- Coagulation Market in Colombia
- Flow Cytometry Market in Colombia
- Non-infectious Disease Molecular Market in Colombia
- Market Participants
- Annar Diagnóstica Import SAS
- Becton Dickinson de Colombia Ltda
- Bio-Rad Laboratories, Inc.
- Laboratorio DAI de Colombia
- Market Share
- Table 5-5: IVD Market Share by Company, Colombia, 2020
- Figure 5-11: IVD Market Colombia, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 6: MEXICO
- OVERVIEW AND DEMOGRAPHICS
- Table 6-1: Key Facts, Mexico (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Mexico
- Table 6-2: Health System and Indicators, Mexico (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 6-3: Economic Profile, Mexico (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Mexico
- IVD MARKET ANALYSIS – MEXICO
- Total Market Size
- Table 6-4: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Mexico by Segment
- Figure 6-1: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 6-2: Average Growth of IVD Markets in Mexico (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Mexico
- Figure 6-3: Clinical Chemistry Market in Mexico by Segment (general chemistries, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-4: Clinical Chemistry Market in Mexico, Market Participant Share (%), 2020
- Immunoassay Market in Mexico
- Figure 6-5: Immunoassay Market in Mexico by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-6: Immunoassay Market in Mexico, Market Participant Share (%), 2020
- Immunoassay Microbiology Market in Mexico
- Immunoassay (non-Microbiology) Market in Mexico
- Microbiology Market in Mexico
- Figure 6-7: Microbiology Market in Mexico by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 6-8: Microbiology Market in Mexico, Market Participant Share (%), 2020
- POC Market in Mexico
- Figure 6-9: POC Market in Mexico by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Histology Market in Mexico
- Figure 6-10: Histology Market in Mexico, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Mexico
- Coagulation Market in Mexico
- Flow Cytometry Market in Mexico
- Non-infectious Disease Molecular Market in Mexico
- Market Participants
- Siemens Healthcare Diagnostics S. de RL de CV
- Market Share
- Table 6-5: IVD Market Share by Company, Mexico, 2020
- Figure 6-11: IVD Market Mexico, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 7: PERU
- OVERVIEW AND DEMOGRAPHICS
- Table 7-1: Key Facts, Peru (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Peru
- Table 7-2: Health System and Indicators, Peru (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 7-3: Economic Profile, Peru (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Peru
- IVD MARKET ANALYSIS – PERU
- Total Market Size
- Table 7-4: Peru IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Peru by Segment
- Figure 7-1: Peru IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 7-2: Average Growth of IVD Markets in Peru (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Peru
- Figure 7-3: Clinical Chemistry Market in Peru by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-4: Clinical Chemistry Market in Peru, Market Participant Share (%), 2020
- Immunoassay Market in Peru
- Figure 7-5: Immunoassay Market in Peru by Segment (infectious disease, cardiac markers, tumor markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-6: Immunoassay Market in Peru, Market Participant Share (%), 2020
- Immunoassay Microbiology Market in Peru
- Immunoassay (non-Microbiology) Market in Peru
- Blood Banking Market in Peru
- Microbiology Market in Peru
- Figure 7-7: Microbiology Market in Peru by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- Figure 7-8: Microbiology Market in Peru, Market Participant Share (%), 2020
- Molecular/NAT Microbiology Market in Peru
- POC Market in Peru
- Figure 7-9: POC Market in Peru by Segment (glucose, other), Estimate and Forecast, 2020-2025 ($US thousands)
- Histology Market in Peru
- Figure 7-10: Histology Market in Peru, by Segment (primary, advanced) Estimate and Forecast, 2020-2025 ($US thousands)
- Hematology Market in Peru
- Coagulation Market in Peru
- Flow Cytometry Market in Peru
- Non-infectious Disease Molecular Market in Peru
- Market Participants
- Beckman Coulter Peru – Danaher
- Becton Dickinson del Uruguay SA Peru Branch
- Jampar Multiplest Internacional
- Market Share
- Table 7-5: IVD Market Share by Company, Peru, 2020
- Figure 7-11: IVD Market Peru, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 8: VENEZUELA
- OVERVIEW AND DEMOGRAPHICS
- Table 8-1: Key Facts, Venezuela (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)
- ECONOMY AND HEALTH FUNDING
- History of the Healthcare System of Venezuela
- Table 8-2: Health System and Indicators, Peru (Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)
- Health Expenditures as Percentage of GDP
- Table 8-3: Economic Profile, Venezuela (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2019
- Testing for COVID-19 in Venezuela
- IVD MARKET ANALYSIS – VENEZUELA
- Total Market Size
- Table 8-4: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2020-2025 (in $US thousands)
- IVD Market in Venezuela by Segment
- Figure 8-1: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) %, 2020
- Figure 8-2: Average Growth of IVD Markets in Venezuela (CAGR 2020 to 2025) %
- Clinical Chemistry Market in Venezuela
- Figure 8-3: Clinical Chemistry Market in Venezuela by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2020-2025 ($US thousands)
- Immunoassay Market in Venezuela
- Figure 8-4: Immunoassay Market in Venezuela by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2020-2025 ($US thousands)
- Microbiology Market in Venezuela
- Figure 8-5: Microbiology Market in Venezuela by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2020-2025 ($US thousands)
- POC Market in Venezuela
- Histology Market in Venezuela
- Hematology Market in Venezuela
- Coagulation Market in Venezuela
- Flow Cytometry Market in Venezuela
- Non-infectious Disease Molecular Market in Venezuela
- Market Participants
- Productos Roche SA – Roche Diagnostica
- Market Share
- Table 8-6: IVD Market Share by Company, Venezuela, 2020
- Figure 8-7: IVD Market Venezuela, Market Participant Share (%), 2020
- Conclusions and Recommendations
CHAPTER 9: LATIN AMERICA IVD MARKET SUMMARY
- DEMOGRAPHIC OVERVIEW
- Table 9-1: Demographics in Select Latin American Countries, 2020
- Figure 9-1: Population Comparison, Select Latin American Countries, 2020 (population in millions)
- Figure 9-2: Population Growth, Select Latin American Countries, 2020-2030 (%)
- Figure 9-3: Aging Population as a % of Total Population, Select Latin American Countries, 2020 (%)
- Figure 9-4: Life Expectancy at Birth by LATAM Country (Average 76 Years), 2020 (years)
- Table 9-2: Leading Causes of Death by Country, LATAM 2020
- BRIEF ECONOMIC OVERVIEW
- GDP in the Latin American Region
- Table 9-3: GDP in Select Latin American Countries, 2019
- Figure 9-5: GDP Comparison, Select Latin American Countries, 2019 (billions USD)
- Figure 9-6: GDP per Capita, Select Latin American Countries, 2019 (USD)
- Health Expenditure in Latin America
- Figure 9-7: Health Spending as a Percent of GDP by LATAM Country, 2019
- IVD Spending per Capita
- THE IVD MARKET IN LATIN AMERICA
- Table 9-4: IVD in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) 2020-2025 in $US thousands
- Figure 9-8: IVD in Latin America by Country, 2020-2025
- Figure 9-9: IVD in Latin America, Distribution of Sales by Select Country, 2020
- IVD Market Participation in Latin America
- Figure 9-10: IVD Market Share by Participant, LATAM, 2020
- Conclusions, Recommendations and Market Attractiveness
- Table 9-5: IVD Attractiveness by LATAM Country, 2020-2025
- Figure 9-11: IVD Market Attractiveness by LATAM County, 2020-2025
